Byetta 250 ug/mL
exenatide · INJECTION · AstraZeneca Pharmaceuticals LP
Byetta (exenatide) is an injectable medication used to help lower blood sugar in adults with type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists, which work by stimulating the pancreas to release insulin when blood sugar levels are high.
Key Facts
- Brand Name
- Byetta
- Generic Name
- exenatide
- NDC Code (Product)
0310-6512- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 250 ug/mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA021773
- Drug Class
- GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 12/10/2014
Recall History
No Recall HistoryFrequently Asked Questions
What is Byetta used for?
Byetta (exenatide) is an injectable medication used to help lower blood sugar in adults with type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists, which work by stimulating the pancreas to release insulin when blood sugar levels are high.
Is Byetta a controlled substance?
Byetta is not classified as a controlled substance by the DEA.
What is the generic name for Byetta?
The generic name for Byetta is exenatide. There are 2 other brand versions of exenatide.
What is the NDC code for Byetta 250 ug/mL?
The NDC (National Drug Code) for Byetta 250 ug/mL is 0310-6512, listed by AstraZeneca Pharmaceuticals LP.